MXPA03000714A - Metodo para reducir exacerbaciones relacionadas con enfermedad de obstruccion pulmonar cronica. - Google Patents

Metodo para reducir exacerbaciones relacionadas con enfermedad de obstruccion pulmonar cronica.

Info

Publication number
MXPA03000714A
MXPA03000714A MXPA03000714A MXPA03000714A MXPA03000714A MX PA03000714 A MXPA03000714 A MX PA03000714A MX PA03000714 A MXPA03000714 A MX PA03000714A MX PA03000714 A MXPA03000714 A MX PA03000714A MX PA03000714 A MXPA03000714 A MX PA03000714A
Authority
MX
Mexico
Prior art keywords
copd
exacerbations associated
reducing exacerbations
reducing
exacerbations
Prior art date
Application number
MXPA03000714A
Other languages
English (en)
Spanish (es)
Inventor
Jeffrey D Edelson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MXPA03000714A publication Critical patent/MXPA03000714A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA03000714A 2000-07-27 2001-07-26 Metodo para reducir exacerbaciones relacionadas con enfermedad de obstruccion pulmonar cronica. MXPA03000714A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22127500P 2000-07-27 2000-07-27
PCT/US2001/023542 WO2002009689A1 (fr) 2000-07-27 2001-07-26 Procede pour reduire les exacerbations associees a la bpco

Publications (1)

Publication Number Publication Date
MXPA03000714A true MXPA03000714A (es) 2003-06-04

Family

ID=22827112

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000714A MXPA03000714A (es) 2000-07-27 2001-07-26 Metodo para reducir exacerbaciones relacionadas con enfermedad de obstruccion pulmonar cronica.

Country Status (16)

Country Link
EP (1) EP1320361A4 (fr)
JP (1) JP2004505039A (fr)
KR (1) KR20030019620A (fr)
CN (1) CN1444476A (fr)
AR (1) AR029984A1 (fr)
AU (2) AU7902301A (fr)
BR (1) BR0112682A (fr)
CA (1) CA2417336A1 (fr)
CZ (1) CZ2003141A3 (fr)
HU (1) HUP0300685A3 (fr)
IL (1) IL153919A0 (fr)
MX (1) MXPA03000714A (fr)
NO (1) NO20030332D0 (fr)
PL (1) PL365612A1 (fr)
WO (1) WO2002009689A1 (fr)
ZA (1) ZA200300476B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
EP2100599A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100598A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2510928A1 (fr) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
KR102087661B1 (ko) * 2018-07-27 2020-03-11 강원대학교산학협력단 Ｇｅｂｒ―７ｂ 화합물을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) * 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
SE9902937D0 (sv) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
DZ3249A1 (fr) * 1999-10-29 2001-05-10 Smithkline Beecham Corp Procédé d'administration d'un inhibiteur phosphodiesterase 4

Also Published As

Publication number Publication date
KR20030019620A (ko) 2003-03-06
AR029984A1 (es) 2003-07-23
CZ2003141A3 (cs) 2004-07-14
IL153919A0 (en) 2003-07-31
EP1320361A1 (fr) 2003-06-25
AU7902301A (en) 2002-02-13
HUP0300685A3 (en) 2004-10-28
NO20030332L (no) 2003-01-22
AU2001279023B2 (en) 2005-11-10
HUP0300685A2 (hu) 2003-12-29
BR0112682A (pt) 2003-06-24
CA2417336A1 (fr) 2002-02-07
NO20030332D0 (no) 2003-01-22
JP2004505039A (ja) 2004-02-19
ZA200300476B (en) 2004-04-23
WO2002009689A1 (fr) 2002-02-07
EP1320361A4 (fr) 2006-04-05
CN1444476A (zh) 2003-09-24
PL365612A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
HK1057638A1 (en) Match control method.
ZA200301584B (en) Method for preparing iron oxides.
ZA200105294B (en) Method for producing L-phenylephrine hydrochloride.
AU7090201A (en) Method
MXPA03000714A (es) Metodo para reducir exacerbaciones relacionadas con enfermedad de obstruccion pulmonar cronica.
AU2001292720A1 (en) Method for performing programming by plain text requests
ZA200402775B (en) Process for reducing residual isocyanate.
ZA200108623B (en) Process for preparing imidachloprid.
IL144992A0 (en) Method for treating copd
HK1033551A1 (en) Method for treating copd.
GB0018839D0 (en) Method for process-driven knowledge activation
EP1397043A4 (fr) Procedes d'immunisation genetique
AU6898101A (en) Method for producing 2-chloro-5-chloromethyl-1,3-thiazole
HK1044780A1 (en) Method for producing cyclo-)asp-dphe-nmeval-arg-gly).
ZA200202504B (en) Process for making wine.
GB2366664B (en) Control method
EP1365967A4 (fr) Receptacle pour le transport d'une bouteille
HUP0105202A2 (en) Method for datatransmission
AU2002354431A8 (en) Method for graphical authentication
HUP0401401A3 (en) Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
GC0000055A (en) Method for making dimethylnaphthalenes.
ZA9973B (en) Method for treating COPD.
GB0019822D0 (en) Method and means for additional carriage space
ZA200105584B (en) Process.
MXPA02012807A (es) Metodo de influencia en formaciones atmosfericas.